\subsection{Age-specific parameters}

Age-structured parameters are presented in Table \ref{tab:age_params}.

\begin{table}
    \begin{threeparttable}
    \begin{tabular}{| p{2cm} | p{2.5cm} | p{3cm} | p{3cm} | p{2.5cm}|}
        \hline
        Age group (years) & Clinical fraction\tnote{a} & 
        Relative susceptibility to infection & Infection fatality rate & 
        Proportion of symptomatic patients hospitalised \\
        \hline
        0 to 4 & 0.533 & 0.36 & $3\times10^{-5}$ & 0.029 \\
        \hline
        5 to 9 & 0.533 & 0.36 & $1\times10^{-5}$ & 0.029 \\
        \hline
        10 to 14 & 0.533 & 0.36 & $1\times10^{-5}$ & 0.014 \\
        \hline
        15 to 19 & 0.533 & 1 & $3\times10^{-5}$ & 0.014 \\
        \hline
        20 to 24 & 0.679 & 1 & $6\times10^{-5}$ & 0.030 \\
        \hline
        25 to 29 & 0.679 & 1 & $1.3\times10^{-4}$ & 0.030 \\
        \hline
        30 to 34 & 0.679 & 1 & $2.4\times10^{-4}$ & 0.047 \\
        \hline
        35 to 39 & 0.679 & 1 & $4.0\times10^{-4}$ & 0.047 \\
        \hline
        40 to 44 & 0.679 & 1 & $7.5\times10^{-4}$ & 0.081 \\
        \hline
        45 to 49 & 0.679 & 1 & $1.21\times10^{-3}$ & 0.081 \\
        \hline
        50 to 54 & 0.679 & 1 & $2.07\times10^{-3}$ & 0.128 \\
        \hline
        55 to 59 & 0.679 & 1 & $3.23\times10^{-3}$ & 0.128 \\
        \hline
        60 to 64 & 0.803 & 1 & $4.56\times10^{-3}$ & 0.221 \\
        \hline
        65 to 69 & 0.803 & 1.41 & $1.075\times10^{-2}$ & 0.221 \\
        \hline
        70 to 74 & 0.803 & 1.41 & $1.674\times10^{-2}$ & 0.389 \\
        \hline
        75 and above & 0.803 & 1.41 & $5.748\times10^{-2}$\tnote{b} & 0.471 \\
        \hline
        Justification and source & 
        Table 1 of systematic review and meta-analysis with appropriate accounting for testing during the pre-symptomatic period. & 
        Conversion of odds ratios presented in Table S15 of Zhang et al. 2020 to relative risks using data presented in Table S14 of the same study.\tnote{c} &
        Estimated from pooled analysis of data from 45 countries from Table S3 of O'Driscoll et al \cite{odriscoll-2021}. 
        Values consistent with previous estimates using serosurveys performed in Spain \cite{RN21}. &
        Table 1.1 from NNDSS report on COVID-19 cases in Australia to May 2021 \\ 
        \hline
	\end{tabular}
	\caption{Age-stratified parameters not varied during calibration, or varied through a common multiplier.}
	\label{tab:age_params}
    \begin{tablenotes}
        \item[a] Proportion of incident cases developing symptoms.
        \item[b] Weighted average of IFR estimates for 70 to 79 and 80 and above age groups.
        \item[c] Note the relative magnitude of these values are similar to those estimated by the analysis we use to estimate the age-specific clinical fraction.
    \end{tablenotes}
    \end{threeparttable}
\end{table}
